Current Edition


Merck’s Hilleman Laboratories tees up $58M investment at new Singapore vaccine hub

Singapore has attracted a slate of vaccine heavyweights in recent years. Now, a Merck joint venture is getting in on the action, following in the …

Continue Reading →
Asia Pacific

Singapore, with strict drug laws, to develop synthetic marijuana compounds

Singapore is funding research on medical treatments containing synthetically-derived compounds of the marijuana plant Singapore, known for some of the world’s most stringent drug laws, …

Continue Reading →